Anil Piya
Pediatric Endocrinology · Savannah, GANPI 1841446408
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (34.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Arbor Pharmaceuticals, Inc. at 32.1% of the total. Reporting peaked in 2022 at $5,377 and has fallen 86.0% since, to $755 in 2025.
Across 195 payments — averaging $71.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arbor Pharmaceuticals, Inc.$4K
- Mannkind Corporation$4K
- Ascendis Pharma Endocrinology Inc$1K
- Tolmar Pharmaceuticals, Inc.$698
- Novo Nordisk$603
- AbbVie$418
- plus $3K from 24 others
Across 1 payment — averaging $577.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$577
What the payments were for
- Consulting fees$2,38017%
- Speaking & faculty fees$3,87528%
- Travel & lodging$2,59219%
- Food & beverage$4,87435%
- Education$2512%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arbor Pharmaceuticals, Inc. | 17 | $4,484 |
| Mannkind Corporation | 8 | $3,505 |
| Ascendis Pharma Endocrinology Inc | 11 | $1,041 |
| Tolmar Pharmaceuticals, Inc. | 5 | $698 |
| Novo Nordisk | 18 | $603 |
| AbbVie | 17 | $418 |
| Insulet Corporation | 12 | $412 |
| AstraZeneca(2 entities) | 7 | $357 |
| Azurity Pharmaceuticals, Inc. | 7 | $241 |
| Ultragenyx Pharmaceutical Inc. | 7 | $237 |
| Xeris Pharmaceuticals, Inc. | 11 | $218 |
| Pfizer | 9 | $208 |
| Medtronic | 4 | $186 |
| Sanofi-aventis U.S. LLC | 8 | $154 |
| Rhythm Pharmaceuticals, Inc. | 7 | $149 |
| BETA Bionics, Inc. | 1 | $123 |
| Dexcom, Inc. | 5 | $117 |
| Tolmar, Inc. | 6 | $105 |
| Zealand Pharma US, Inc. | 4 | $94 |
| Ferring Pharmaceuticals Inc. | 5 | $93 |
| Eton Pharmaceuticals, Inc. | 3 | $83 |
| Tandem Diabetes Care, Inc. | 4 | $82 |
| Abbott | 4 | $77 |
| Vistapharm, Inc. | 4 | $77 |
| Kyowa Kirin, Inc. | 2 | $51 |
| Endo Pharmaceuticals Inc. | 3 | $48 |
| Biomarin Pharmaceutical Inc. | 2 | $47 |
| Lilly USA, LLC | 2 | $28 |
| Sandoz | 1 | $22 |
| IBSA Pharma Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Triptodur$4,408
- AFREZZA$3,457
- SKYTROFA$875
- FENSOLVI$680
- iLet Bionic Pancreas$368
- Omnipod$125
- iLet Insulin Infusion Kit Inset$123
- iLet Insulin Infusion Kit Contact Detach$123
- MINIMED 780G$122
- Sogroya$120
- Lupron Depot$110
How this compares
$13,972 in reported general payments places this provider in the 85th percentile of 30 pediatric endocrinology providers in Georgia.
Other pediatric endocrinology in Savannah
- Quentin VanmeterAtlanta$215K
- Toni KimSandy Springs$160K
- Eric FelnerAtlanta$24K
- Jessica HutchinsMacon$21K
- Juliana Vera OrtizNewnan$13K
- Daniel HsiaAtlanta$6K
- Jacqueline ChanAugusta$3K
- Tarek BisatMacon$3K
- Eric VelazquezMacon$3K
- Joey LowCumming$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.